NCT00642577View on ClinicalTrials.gov

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.

PHASE3CompletedINTERVENTIONAL

Enrollment

214

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Colorectal Cancer

Interventions

DRUG

bevacizumab [Avastin]

5mg/kg iv every 2 weeks

DRUG

irinotecan

125mg/m2 iv weekly for 4 weeks of each 6 week cycle

DRUG

leucovorin

20mg/m2 iv weekly for 4 weeks of each 6 week cycle

DRUG

fluorouracil

500mg/m2 iv weekly for 4 weeks of each 6 week cycle

Trial Locations (12)

100021

Beijing

100036

Beijing

100071

Beijing

200003

Shanghai

200080

Shanghai

210002

Nanjing

266003

Qingdao

300060

Tianjin

400042

Chongqing

430030

Wuhan

510060

Guangzhou

510515

Guangdong

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00642577 - A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | Biotech Hunter | Biotech Hunter